Pancreatic Cancer Research

ResearcherQingdao UniversityNo recent work listed

Dongsheng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-0097-8223; OpenAlex author ID A5100450574. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. The Second-Generation Proteasome Inhibitor Ixazomib Enhances the Anticancer Effects of Gemcitabine or Fluorouracil in Pancreatic Cancer Cells Co-author DOI 10.21203/rs.3.rs-1374979/v1↗
  2. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Last author DOI 10.1038/labinvest.2010.201↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenjing Sun · 1 shared paper, 2022 · strength 0.17
  2. Jianjun Gao · 1 shared paper, 2022 · strength 0.17
  3. Hao Wang · 1 shared paper, 2022 · strength 0.17
  4. Xiangyu Zhong · 1 shared paper, 2022 · strength 0.17
  5. Dong Chen · 1 shared paper, 2011 · strength 0.03
  6. Kejun Zhang · 1 shared paper, 2011 · strength 0.03
  7. Jingyu Cao · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.